No CrossRef data available.
Article contents
Spectrum of clinical presentation of COVID-19 in paediatric patients with cardiomyopathy and heart failure
Published online by Cambridge University Press: 09 March 2021
Abstract
As the United States’ original epicenter of the COVID-19 pandemic and one of the leading national paediatric heart failure/cardiomyopathy programs, we describe our experience with the spectrum of COVID-19 in the paediatric heart failure population.
Keywords
- Type
- Brief Report
- Information
- Copyright
- © The Author(s), 2021. Published by Cambridge University Press
References
Tomasoni, D, Italia, L, Adamo, M, et al. COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail 2020; 6: 957–966.CrossRefGoogle Scholar
Clerkin, KJ, Fried, JA, Raikhelkar, J, et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation 2020; 20: 1648–1655.CrossRefGoogle Scholar
Cheung, EW, Zachariah, P, Gorelik, M, et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA 2020; 3: 294–296.CrossRefGoogle Scholar
Fried, JA, Ramasubbu, K, Bhatt, R, et al. The variety of cardiovascular presentations of COVID-19. Circulation 2020; 23: 1930–1936.CrossRefGoogle Scholar